{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:43:23Z","timestamp":1792226603175,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04121-5","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:12:40Z","timestamp":1755522760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global burden, temporal trends, and health workforce correlations of gallbladder and biliary tract cancer: a comprehensive analysis from 1990 to 2021 with projections to 2046"],"prefix":"10.1186","volume":"25","author":[{"given":"Fangyi","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayou","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"4121_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh D-Y, Zhu AX. Biliary tract cancer. Lancet. 2021;397:428\u201344.","journal-title":"Lancet"},{"key":"4121_CR2","doi-asserted-by":"publisher","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","volume":"27","author":"JW Valle","year":"2016","unstructured":"Valle JW, et al. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28\u201337.","journal-title":"Ann Oncol"},{"key":"4121_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17:557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4121_CR4","doi-asserted-by":"publisher","first-page":"100378","DOI":"10.1016\/j.esmoop.2021.100378","volume":"7","author":"A Lamarca","year":"2022","unstructured":"Lamarca A, Edeline J, Goyal L. How I treat biliary tract cancer. ESMO Open. 2022;7:100378.","journal-title":"ESMO Open"},{"key":"4121_CR5","doi-asserted-by":"publisher","first-page":"e16199","DOI":"10.1111\/liv.16199","volume":"45","author":"S Lei","year":"2025","unstructured":"Lei S, et al. Global burden, trends, and inequalities of gallbladder and biliary tract cancer, 1990\u20132021: A decomposition and Age\u2013Period\u2013Cohort analysis. Liver Int. 2025;45:e16199.","journal-title":"Liver Int"},{"key":"4121_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hep.32198","volume":"75","author":"SS Jackson","year":"2022","unstructured":"Jackson SS, et al. Menopausal hormone therapy and risk of biliary tract cancers. Hepatology. 2022;75:309\u201321.","journal-title":"Hepatology"},{"key":"4121_CR7","doi-asserted-by":"publisher","unstructured":"Ceci L, et al. Gallstone and gallbladder disease: biliary tract and cholangiopathies. In: Prakash YS, editor. Comprehensive physiology. Wiley; 2023. pp. 4909\u201343. https:\/\/doi.org\/10.1002\/cphy.c220028.","DOI":"10.1002\/cphy.c220028"},{"key":"4121_CR8","doi-asserted-by":"publisher","unstructured":"Bai Y, et al. Gastrointestinal traits, common inflammatory disorders, gallstones, and biliary tract cancer: A network Mendelian randomization study. J Adv Res. 2025;S2090123225001511. https:\/\/doi.org\/10.1016\/j.jare.2025.03.010.","DOI":"10.1016\/j.jare.2025.03.010"},{"key":"4121_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, et al. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4121_CR10","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389.","journal-title":"J Hepatol"},{"key":"4121_CR11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/HEP.0000000000000748","volume":"79","author":"Y-H Huang","year":"2024","unstructured":"Huang Y-H, et al. Association of tea and coffee consumption and biliary tract cancer risk: the biliary tract cancers pooling project. Hepatology. 2024;79:1324\u201336.","journal-title":"Hepatology"},{"key":"4121_CR12","doi-asserted-by":"publisher","first-page":"115387","DOI":"10.1016\/j.ejca.2025.115387","volume":"220","author":"CH Maeng","year":"2025","unstructured":"Maeng CH, Han K, Hong JY, Park J-H. Association between premature menopause and the risk of biliary tract cancer: A nationwide cohort study. Eur J Cancer. 2025;220:115387.","journal-title":"Eur J Cancer"},{"key":"4121_CR13","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853\u201365.","journal-title":"Lancet"},{"key":"4121_CR14","doi-asserted-by":"publisher","unstructured":"Oh D-Y, et al. Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. J Hepatol. 2025;S0168827825022019. https:\/\/doi.org\/10.1016\/j.jhep.2025.05.003.","DOI":"10.1016\/j.jhep.2025.05.003"},{"key":"4121_CR15","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari AJ, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"4121_CR16","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2100\u201332.","journal-title":"Lancet"},{"key":"4121_CR17","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"M Brauer","year":"2024","unstructured":"Brauer M, et al. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"4121_CR18","doi-asserted-by":"publisher","first-page":"e1003138","DOI":"10.1371\/journal.pmed.1003138","volume":"17","author":"X Cheng","year":"2020","unstructured":"Cheng X, et al. Population ageing and mortality during 1990\u20132017: A global decomposition analysis. PLoS Med. 2020;17:e1003138.","journal-title":"PLoS Med"},{"key":"4121_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(22)00532-3","volume":"399","author":"A Haakenstad","year":"2022","unstructured":"Haakenstad A, et al. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;399:2129\u201354.","journal-title":"Lancet"},{"key":"4121_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","volume":"20","author":"M Knoll","year":"2020","unstructured":"Knoll M, et al. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20:257.","journal-title":"BMC Med Res Methodol"},{"key":"4121_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.21147\/j.issn.1000-9604.2024.05.02","volume":"36","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Epidemiology of biliary tract cancer in china: A narrative review. Chin J Cancer Res. 2024;36:474\u201388.","journal-title":"Chin J Cancer Res"},{"key":"4121_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001200","author":"QT Vu","year":"2024","unstructured":"Vu QT, et al. International trends in biliary tract cancer\u2013related mortality, 2000\u20132022: an observational study of the world health organization mortality database. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000001200.","journal-title":"Hepatology"},{"key":"4121_CR23","doi-asserted-by":"crossref","unstructured":"Yoon J, G, et al. Molecular characterization of biliary tract Cancer predicts chemotherapy and programmed death 1\/programmed death-Ligand 1 Blockade responses. Hepatology. 2021;74:1914\u201331.","DOI":"10.1002\/hep.31862"},{"key":"4121_CR24","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.lanepe.2024.101171","volume":"50","author":"L Rimassa","year":"2025","unstructured":"Rimassa L, et al. Mapping the landscape of biliary tract cancer in europe: challenges and controversies. Lancet Reg Health - Europe. 2025;50:101171.","journal-title":"Lancet Reg Health - Europe"},{"key":"4121_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jhep.2024.10.020","volume":"82","author":"S Hwang","year":"2025","unstructured":"Hwang S, et al. Concordance of ctdna and tissue genomic profiling in advanced biliary tract cancer. J Hepatol. 2025;82:649\u201357.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04121-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T01:51:53Z","timestamp":1757469113000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04121-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4121"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04121-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"596"}}